Mark Miller

Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants.

E. E. Mannick, Luis Eduardo Bravo, Guillermo Zarama et al. · PubMed · 1996 · 488 citations

Inflammation, Gastrointestinal Oncology, Reactive Nitrogen Specie +14

Amelioration of chronic ileitis by nitric oxide synthase inhibition.

Mark Miller, H Sadowska-Krowicka, Somporn Chotinaruemol et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 411 citations

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*

Edward A. Panacek, John C. Marshall, Timothy E. Albertson et al. · Critical Care Medicine · 2004 · 380 citations

Adequacy of Early Empiric Antibiotic Treatment and Survival in Severe Sepsis: Experience from the MONARCS Trial

Rodger D. MacArthur, Mark Miller, Timothy Albertson et al. · Clinical Infectious Diseases · 2004 · 271 citations

Severe Sepsis, Suspected Sepsis, Antibiotics +15

Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients

Peter Phillips, Stephen Shafran, Gary Garber et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1997 · 220 citations

Antifungal Agent, Non-neutropenic Patients, Antifungal Agents +6